Targeting inflammation to reduce cardiovascular disease risk

Maffia, P. and Cirino, G. (2017) Targeting inflammation to reduce cardiovascular disease risk. British Journal of Pharmacology, 174(22), pp. 3895-3897. (doi: 10.1111/bph.14039) (PMID:29080212) (PMCID:PMC5659995)

[img]
Preview
Text
148593.pdf - Accepted Version

491kB

Abstract

This joint themed section of the British Journal of Pharmacology and the British Journal of Clinical Pharmacology stems from a joint British Pharmacological Society – Italian Society of Pharmacology symposium held at the 37th National Congress of the Italian Society of Pharmacology in Naples (Italy) from 27 to 30 October 2015.

Item Type:Articles (Editorial)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Maffia, Professor Pasquale
Authors: Maffia, P., and Cirino, G.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:British Journal of Pharmacology
Publisher:Wiley
ISSN:0007-1188
ISSN (Online):1476-5381
Published Online:27 October 2017
Copyright Holders:Copyright © 2017 The British Pharmacological Society
First Published:First published in British Journal of Pharmacology 174(22): 3895-3897
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
614711Defining innate and adaptive immune functions of plasmacytoid dendritic cells in atherosclerosis.Pasquale MaffiaBritish Heart Foundation (BHF)PG/12/81/29897III -IMMUNOLOGY
617771BHF centre of excellenceRhian TouyzBritish Heart Foundation (BHF)RE/13/5/30177RI CARDIOVASCULAR & MEDICAL SCIENCES
682541NanoMATePasquale MaffiaEuropean Commission (EC)661369III -IMMUNOLOGY
644661In Situ Nanoparticle Assemblies for Healthcare Diagnostics and TherapyPasquale MaffiaEngineering and Physical Sciences Research Council (EPSRC)EP/L014165/1III -IMMUNOLOGY
718631Selective targeting of NF-??B by Bcl-3 in the control of vascular injuryGianluca GrassiaTenovus Scotland (TENOVUS)S15/24III -IMMUNOLOGY